We are live on ! Find out more
PTJ

Paul Tudor Jones Tudor Investment Corp

AUM $71.9B
1-Year Est. Return 42.37%
 

Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.

This Fund
S&P 500
This Quarter Est. Return
+6.95%
1 Year Est. Return
+42.37%
3 Year Est. Return
+108.76%
5 Year Est. Return
+114.43%
10 Year Est. Return
+640.77%
AUM
$6.46B
AUM Growth
+$1.4B
Cap. Flow
+$1.28B
Cap. Flow %
19.8%
Top 10 Hldgs %
6.83%
Holding
3,136
New
836
Increased
737
Reduced
670
Closed
800

Sector Composition

Rank Sector Weight
1 Technology 16.69%
2 Industrials 11.81%
3 Healthcare 11.19%
4 Financials 10.02%
5 Consumer Discretionary 9.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UHT
2976
Universal Health Realty Income Trust
UHT
$573M
-8,250
Closed -$394K
UNIT
2977
Uniti Group
UNIT
$2.42B
-15,967
Closed -$88K
UNP icon
2978
CALL
Union Pacific
UNP
$183B
-6,700
Closed -$1.39M
UNP icon
2979
Union Pacific
UNP
$183B
-35,632
Closed -$7.38M
UNP icon
2980
PUT
Union Pacific
UNP
$183B
-6,200
Closed -$1.28M
URBN icon
2981
Urban Outfitters
URBN
$6.36B
-129,097
Closed -$3.08M
USB icon
2982
CALL
US Bancorp
USB
$96.7B
-22,900
Closed -$997K
USNA icon
2983
Usana Health Sciences
USNA
$250M
-12,047
Closed -$641K
USPH icon
2984
PUT
US Physical Therapy
USPH
$1.17B
-2,900
Closed -$235K
UTL icon
2985
Unitil
UTL
$970M
-4,312
Closed -$221K
VIAV icon
2986
Viavi Solutions
VIAV
$9.6B
-107,936
Closed -$1.13M
VIRT icon
2987
PUT
Virtu Financial
VIRT
$6B
-20,900
Closed -$426K
VLO icon
2988
Valero Energy
VLO
$100B
-29,130
Closed -$3.91M
VLY icon
2989
Valley National Bancorp
VLY
$7.82B
-230,551
Closed -$2.61M
VMEO
2990
DELISTED
Vimeo
VMEO
-142,074
Closed -$487K
VNDA icon
2991
Vanda Pharmaceuticals
VNDA
$319M
-10,740
Closed -$79K
VRNT
2992
DELISTED
Verint Systems
VRNT
-35,595
Closed -$1.29M
VRT icon
2993
CALL
Vertiv
VRT
$101B
-10,900
Closed -$149K
VRTX icon
2994
Vertex Pharmaceuticals
VRTX
$139B
-7,580
Closed -$2.19M
VTLE
2995
DELISTED
Vital Energy
VTLE
-24,806
Closed -$1.24M
VUZI icon
2996
Vuzix
VUZI
$248M
-83,453
Closed -$304K
W icon
2997
Wayfair
W
$13.9B
-25,963
Closed -$1.15M
WAL icon
2998
PUT
Western Alliance Bancorporation
WAL
$8.69B
-4,800
Closed -$287K
WDC icon
2999
CALL
Western Digital
WDC
$166B
-31,752
Closed -$757K
WDC icon
3000
PUT
Western Digital
WDC
$166B
-23,285
Closed -$556K

Similar funds

Paul Tudor Jones's Q1 2023 Portfolio in Review

As of Q1 2023, Paul Tudor Jones held 3,136 positions worth $6.46B, up 28% from $5.06B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.

Paul Tudor Jones deployed $1.28B of net new capital in Q1 2023, opening 836 new positions and adding to 737 existing holdings. Its largest new stake was Johnson & Johnson: 216,183 shares worth $33.5M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $37.7M trimmed.

  • Paul Tudor Jones's largest Q1 2023 buy was Johnson & Johnson: 216,183 shares worth $33.5M.
  • Paul Tudor Jones added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $47.5M increase.
  • Paul Tudor Jones's biggest Q1 2023 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $37.7M.
  • Paul Tudor Jones fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $51.8M.
  • Paul Tudor Jones's ten largest holdings make up 6.8% of its $6.46B portfolio in Q1 2023.
  • Paul Tudor Jones opened 836 new positions and closed 800 in Q1 2023.
  • Paul Tudor Jones's portfolio value rose 28% quarter-over-quarter to $6.46B.

Based on Tudor Investment Corp's 13F filing for Q1 2023, filed 15 May 2023.